General Information of the Compound
| Compound ID |
CP0391923
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-Benzyl-4-(2-iodo-1H-pyrrol-1-yl)piperidine
1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
254115-95-2
4-(2-iodopyrrolyl)-1-benzylpiperidine
AKOS027449108
BDBM50082171
CHEMBL106635
CTK7C3535
SBB054419
ZINC20358060
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H19IN2
|
||||||||||||||||||
| Molecular Weight |
366.246
|
||||||||||||||||||
| Canonical SMILES |
Ic1cccn1C1CCN(Cc2ccccc2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H19IN2/c17-16-7-4-10-19(16)15-8-11-18(12-9-15)13-14-5-2-1-3-6-14/h1-7,10,15H,8-9,11-13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
LZMIVAWAFVXKJL-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor
Clinical Information about the Compound